Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tijssen

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trialMartin J B Taphoorn, Martin J van den Bent, Murielle E L Mauer, et al.
Journal of Neuro-Oncology|October 29, 2013
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivorsEsther J J Habets, Martin J B Taphoorn, Sylvie Nederend, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trialMartin J van den Bent, Antoine F Carpentier, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, et al.
Neurology|April 12, 2015
CT within 6 hours of headache onset to rule out subarachnoid hemorrhage in nonacademic hospitalsKatelijn M Blok, Gabriel J E Rinkel, Charles B L M Majoie, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trialMartin J B Taphoorn, Martin J van den Bent, Murielle E L Mauer, et al.
Journal of Neuro-Oncology|October 29, 2013
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivorsEsther J J Habets, Martin J B Taphoorn, Sylvie Nederend, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trialMartin J van den Bent, Antoine F Carpentier, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, et al.
Neurology|April 12, 2015
CT within 6 hours of headache onset to rule out subarachnoid hemorrhage in nonacademic hospitalsKatelijn M Blok, Gabriel J E Rinkel, Charles B L M Majoie, et al.
Pageof 12